The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations

Journal of Clinical Investigation

Volumn 98, Issue 2, 1996, Pages 451-459

  Winyard, Paul J D ^a   Risdon, R Anthony ^b   Sams, Virginia R ^c   Dressler, Gregory R ^d   Woolf, Adrian S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Department of Histopathology   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

BCL2; dysplastic kidney; nephrogenesis; PAX2; WT1

Indexed keywords

CYCLINE; DNA; TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; ONCOPROTEIN; PAX2 PROTEIN, HUMAN; PROTEIN BCL 2; TRANSCRIPTION FACTOR PAX2; WT1 PROTEIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY COLLECTING TUBULE; KIDNEY DEVELOPMENT; KIDNEY DYSPLASIA; KIDNEY EPITHELIUM; KIDNEY MALFORMATION; KIDNEY POLYCYSTIC DISEASE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; BIOSYNTHESIS; CHILD; CHRONIC KIDNEY FAILURE; CONGENITAL MALFORMATION; GESTATIONAL AGE; KIDNEY; KIDNEY TUMOR; METABOLISM; NEPHROBLASTOMA; PATHOLOGY; REFERENCE VALUE; SUDDEN INFANT DEATH SYNDROME;

CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; FETUS; GENE EXPRESSION; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY; KIDNEY DISEASES, CYSTIC; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; PAX2 TRANSCRIPTION FACTOR; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REFERENCE VALUES; SUDDEN INFANT DEATH; TRANSCRIPTION FACTORS; WILMS TUMOR; WT1 PROTEINS;

EID: 0029665965     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118811     Document Type: Article

References (61)

1. Gilbert, S.F. 1991. Developmental Biology, Third Edition. Sinauer Associates, Inc. Sunderland, Massachusetts. 376-457.
2. Ryan, G., V. Steele-Perkins, J.F. Morris, F.J. Rauscher III, and G.R. Dressler. 1995. Repression of Pax-2 by WT1 during normal kidney development. Development (Camb.). 121:867-875.
3. Song, D.-L., G. Chalepakis, P. Gruss, and A.L. Joyner. 1996. Two Pax-binding sites are required for early embryonic brain expression of an Engrailed-2 transgene. Development (Camb.). 122:627-635.
4. Gruss, P., and C. Walther. 1992. Pax in development. Cell. 69:719-722.
5. Stapleton, P., A. Weith, P. Urbanek, Z. Kozmik, and M. Busslinger. 1993. Chromosomal localisation of seven Pax genes and cloning of a novel family member, Pax9. Nat. Genet. 3:292-298.
6. Halder, G., P. Callaerts, W.J. Gehring. 1995. Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science (Wash. DC). 267: 1788-1792.
7. Hyatt, G.A., E.A. Schmitt, N. Marsh-Armstrong, P. McCaffery, U.C. Drager, and J.E. Dowling. 1996. Retinoic acid establishes ventral retinal characteristics. Development (Camb.). 122:195-204.
8. Max, E.E., Y. Wakatsuki, M.F. Neurath, and W. Strober. 1995. The role of BSAP in immunoglobulin isotype switching and B-cell proliferation. Curr. Topics Microbiol. Immunol. 194:449-458.
9. Keller, S.A., J.M. Jones, A. Boyle, L.L. Barrow, P.D. Killen, D.G. Green. N.V. Kapousta, P.F. Hitchcock, R.T. Swank, and M.H. Meisler. 1994. Kidney and retinal defects (Krd), a transgene-induced mutation with a deletion of mouse chromosome 19 that includes the Pax2 locus. Genomics. 23:309-320.
10. Matsuo, T., N. Osumi-Yamashita, S. Noji, H. Ohuchi, E. Koyama, F. Myokai, N. Matsuo, S. Taniguchi, H. Doi, S. Iseki, et al. 1993. A mutation in the Pax-6 gene in rat small eye is associated with impaired migration of midbrain crest cells. Nat. Genet. 3:299-304.
11. Goulding, M.D., G. Chalapakis, U. Deutsch, J.R. Erselius, and P. Gruss. 1991. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO (Eur. Mol. Biol. Organ.) J. 10:1135-1147.
12. Wallin, J., H. Eibel, A. Neubuser, J. Wilting, H. Koseki, and R. Balling. 1996. Pax1 is expressed during the development of the thymus epithelium and is required for normal T-cell maturation. Development (Camb.). 122:23-30.
13. Maulbecker, C.C., and P. Gruss. 1993. The oncogenic potential of Pax genes. EMBO (Eur. Mol. Biol. Organ.) J. 12:2361-2367.
14. Read, A.P. 1995. Pax genes - Paired feet in three camps. Nat. Genet. 5: 333-334.
15. Tassabehji, M., A.P. Read, V. E. Newton, M. Patton, P. Gruss, R. Harris, and T. Strachan. 1993. Mutations in the Pax 3 gene causing Waardenburg syndrome type 1 and 2. Nat. Genet. 3:26-30.
16. Hanson, I.M., A. Seawright, K. Hardman, S. Hodgson, D. Zaletayev, G. Fekete, and V. van Heyningen. 1993. Pax 6 mutations in aniridia. Hum. Mol. Genet. 2:915-920.
17. Barr, F.G., N. Galili, J. Holick, J.A. Biegel, G. Rovera, and B.A. Emanuel. 1993. Rearrangement of the Pax3 paired-box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3:113-117.
18. Dressler, G.R., U. Deutsch, K. Chowdhury, H.O. Nornes, P. Gruss. 1990. Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development (Camb.). 109:787-795.
19. Plachov, D., K. Chowdhury, C. Walther, D. Simon, J.-L. Guenet, and P. Gruss. 1990. Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development (Camb.). 110:543-651.
20. Dressler, G.R., and E.C. Douglas. 1992. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc. Natl. Acad. Sci. USA. 89:1179-1183.
21. Dressler, G.R., J.E. Wilkinson, U.W. Rothenpieler, L.T. Patterson, L. Williams-Simons, and H. Westphal. 1993. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature (Lond.). 362:65-67.
22. Torres, M., E. Gomex-Pardo, G.R. Dressler, and P. Gruss. 1995. Pax-2 controls multiple steps of urogenital development. Development (Camb.). 121: 4057-4065.
23. Rothenpieler, U.W., and G.R. Dressler. 1993. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development (Camb.). 119:711-720.
24. Fickenscher, H.R., G. Chalepakis, and P. Gruss. 1993 Murine Pax-2 protein is a sequence-specific trans-activator with expression in the genital system. DNA Cell Biol. 12:381-391.
25. Sanyanusin, P., L.A. Schimmentl, L.A. McNoe, T.A. Ward, M.E.M. Pierpoint, M.J. Sullivan, W.B. Dobyns, and M.R. Eccles. 1995. Mutations of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat. Genet. 9:358-364.
26. Sanyanusin, P., L.A. McNoe, M.J. Sullivan, R.G. Weaver, and M.R. Eccles. 1995. Mutation of PAX2 in two siblings with renal-coloboma syndrome. Hum. Mol. Genet. 4:2183-2184.
27. Battin, J., D. Lacombe, and J.J. Leng. 1993. Familial occurrence of hereditary renal adysplasia with Mullerian anomalies. Clin. Genet. 43:23-24.
28. Eccles, M.R., L.J. Wallis, A.E. Fidler, N.K. Spurr, P.J. Goodfellow, and A.E. Reeve. 1992. Expression of the PAX2 gene in human fetal kidney and Wilm's tumor. Cell Growth & Differ. 3:279-289.
29. Poleev, A., F. Wendler, H. Fickensher, M.S. Zannini, K. Yaginuma, C. Abbott, and D. Plachov. 1995. Distinct functional properties of three human paired-box-protein, PAX 8, isoforms generated by alternative splicing in thyroid, kidney and Wilm's tumors. Eur. J. Biochem. 228:899-911.
30. Sharma, P.M., M. Bowman, B.F. Yu, and S. Sukumar, 1994. A rodent model for Wilm's tumors: embryonal kidney neoplasms induced by N-notroso-N′-methylurea. Proc. Natl. Acad. Sci. USA. 91:9931-9935.
31. Gnarra, J.R., and G.R. Dressler. 1995. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 55:4092-4098.
32. Bernstein, J. 1992. Renal hypoplasia and dysplasia. In Pediatric Kidney Disease. C.M. Edelman, Jr., editor. Little, Brown. Boston, MA. 1121-1138.
33. Ehrich, J.H.H., G. Rizzoni, F.P. Brunner, W. Fassbinder, W. Geerlings, N.P. Mallick, A.E.G. Raine, N.H. Selwood, and G. Tufveson. 1992. Renal replacement therapy for end-stage renal failure before 2 years of age. Nephrol. Dial. Transplant. 7:1171-1177.
34. Potter, E.L. 1972. Normal and Abnormal Development of the Kidney. Year Book Medical Publishers Inc., Chicago. 1-350.
35. Risdon, R.A. 1971. Renal dysplasia. Part 1. A clinico-pathological study of 76 cases. J. Clin. Path. 24:57-71.
36. Winyard, P.J.D., J. Nauta, D.S. Lirenman, P. Hardman, V.R. Sams, R.A. Risdon, and A.S. Woolf. 1996. Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int. 49:135-146.
37. Dungan, J.S., M.T. Fernandez, P.L. Abbitt, S. Thiagarajah, S.S. Howards, and W.A. Hogge. 1990. Multicystic dysplastic kidney: natural history of prenatally detected cases. Prenatal Diag. 10:175-182.
38. Barrett, D.M., and R.E. Wineland. 1980. Renal cell carcinoma in multicystic dysplastic kidney. Urology. 15:152-154.
39. Cromie, W.J., M.S. Engelstein, and J.W. Dickett. 1980. Nodular renal blastema, renal blastema and duplicated collecting systems. J. Urol. 123:100-102.
40. Phelps, D.A., and G.R. Dressler. 1996. Indentification of novel Pax-2 binding sites by chromatin precipitation. J. Biol. Chem. 271: 7978-7985.
41. Larsson, S.H., J.-P. Charlieu, K. Miyagawa, D. Engelkamp, M. Rassoulzadegan, A. Ross, F. Cuzin, V. van Heyningen, and N. Hastie. 1995. Subnuclear localisation of WT1 in splicing of transcription factor domains is regulated by alternative splicing. Cell. 81:391-401.
42. Bravo, R., R. Frank, P.A. Blundell, and H. MacDonald-Bravo. 1987. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature (Lond.). 326:515-517.
43. Hockenberry, D.G., C. Nunez, C. Milliman, R.D. Schreiber, and S.J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.). 348:334-336.
44. Veis, D.J., C.M. Sorenson, J.R. Shutter, and S.J. Korsmeyer. 1994. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell. 75:229-240.
45. Pritchard-Jones, K., S. Flemming, D. Davidson, W.A. Bickmore, D. Porteus, C. Gosden, J. Bard, A. Buckler, J. Pelletier, D. Housman, V. van Heyningen, and N. Hastie. 1990. The candidate Wilm's tumor gene is involved in genitourinary development. Nature (Lond). 346:194-197.
46. Kreidberg, J.A., H. Sariola, J.M. Loring, M. Maeda, J. Pelletier, D. Housman, and R. Jaenisch. 1993. WT-1 is required for early kidney development. Cell. 74:679-691.
47. Hanai, T., N. Usuda, T. Morita, T. Shimizu, and T. Nagata. 1993. Proliferative activity in the kidneys of aging mice evaluated by PCNA/cyclin immunohistochemistry. Cell Mol. Biol. 39:181-191.
48. Mundlos, S., J. Pelletier, A. Darveau, M. Bachmann, A. Winterpacht, and B. Zabel. 1993. Nuclear localisation of the protein encoded by the Wilm's tumor gene WT1 in embryonic and adult tissues. Development (Camb.). 119: 1329-1343.
49. Veis, D.J., and S.J. Korsmeyer. 1994. Bcl-2 protein expression during murine development. Am J Pathol. 145:61-73.
50. Sorenson, C.M., S.A. Rogers, S.J. Korsmeyer, and M.R. Hammerman. 1995. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2 deficient mice. Am. J. Physiol. 268:F73-F81.
51. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerises in vivo with a conserved homologue, bax, that accelerates programmed cell death. Cell. 74:609-619.
52. Maizel, M., and S.B. Simpson. 1983. Primitive ducts of renal dysplasia induced by culturing ureteral buds denuded of condensed renal mesenchyme. Science (Wash. DC). 219:509-510.
53. Qiao, J., D. Cohen, and D. Herzlinger. 1995. The metanephric blastema differentiates into collecting system and nephron epithelia in vitro. Development (Camb.). 121:3207-3214.
54. Santos, O.F.P., E.J.G. Barros, Y.-M. Yang, K. Matsumoto, M. Park, and S.K. Nigam. 1994. Involvement of hepatocyte growth factor in kidney development. Dev. Biol. 163:525-529.
55. Woolf, A.S., M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L.G. Fine, P.S. Jat, M.D. Noble, and E. Gherardi. 1995. Roles of hepatocyte growth factor/scatter factor and met in early development of the metanephros. J. Cell Biol. 128:171-184.
56. Kanwar, Y.S., Z.Z. Liu, A. Kumar, J. Wada, and F.A. Carone. 1995. Cloning of mouse c-ros cDNA, its role in development and relationship to extracellular matrix glycoproteins. Kidney Int. 48:1646-1659.
57. Schuchardt, A., V. D'Agati, L. Larsson-Blomberg, F. Costantini, V. Pachnis. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature (Lond.). 367:319-320.
58. Threadgill, D.W., A. Dlugosz, L.A. Hansen, T. Tennenbaum, U. Lichti, D. Yee, C. LaMantia, T. Mourton, K. Herrup, R.C. Harris, J.A. Barnard, S.H. Yuspa, R.J. Coffey, and T. Magnuson. 1995. Targeted disruption of mouse EGF receptor: effect of Genetic Background on mutant phenotype. Science (Wash. DC). 269:230-234.
59. Sariola, H., M. Saarma, K. Sainio, U. Arumae, J. Palgi, A. Vaatokari, I. Thesleff, and A. Karavanov. 1991. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science (Wash. DC). 254:571-573.
60. Mugrauer, G., and P. Ekblom. 1991. Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney. J. Cell Biol. 112:13-25.
61. Woolf, A.S. 1995. Clinical impact and biological basis of kidney malformations. Semin. Nephrol. 15:361-372.